Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.46
WAT's Cash to Debt is ranked lower than
53% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. WAT: 1.46 )
Ranked among companies with meaningful Cash to Debt only.
WAT' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 1.06 Max: 336.71
Current: 1.46
0
336.71
Equity to Asset 0.48
WAT's Equity to Asset is ranked lower than
69% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. WAT: 0.48 )
Ranked among companies with meaningful Equity to Asset only.
WAT' s Equity to Asset Range Over the Past 10 Years
Min: 0.11  Med: 0.45 Max: 0.7
Current: 0.48
0.11
0.7
Interest Coverage 16.85
WAT's Interest Coverage is ranked lower than
54% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.08 vs. WAT: 16.85 )
Ranked among companies with meaningful Interest Coverage only.
WAT' s Interest Coverage Range Over the Past 10 Years
Min: 5.71  Med: 16.44 Max: 35.92
Current: 16.85
5.71
35.92
F-Score: 5
Z-Score: 6.63
M-Score: -2.49
WACC vs ROIC
6.57%
28.02%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 27.70
WAT's Operating margin (%) is ranked higher than
93% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. WAT: 27.70 )
Ranked among companies with meaningful Operating margin (%) only.
WAT' s Operating margin (%) Range Over the Past 10 Years
Min: 23.05  Med: 26.75 Max: 28.55
Current: 27.7
23.05
28.55
Net-margin (%) 23.33
WAT's Net-margin (%) is ranked higher than
93% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.00 vs. WAT: 23.33 )
Ranked among companies with meaningful Net-margin (%) only.
WAT' s Net-margin (%) Range Over the Past 10 Years
Min: 17.36  Med: 22.34 Max: 25.03
Current: 23.33
17.36
25.03
ROE (%) 23.97
WAT's ROE (%) is ranked higher than
92% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.62 vs. WAT: 23.97 )
Ranked among companies with meaningful ROE (%) only.
WAT' s ROE (%) Range Over the Past 10 Years
Min: 23.6  Med: 38.77 Max: 68.79
Current: 23.97
23.6
68.79
ROA (%) 11.53
WAT's ROA (%) is ranked higher than
87% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.92 vs. WAT: 11.53 )
Ranked among companies with meaningful ROA (%) only.
WAT' s ROA (%) Range Over the Past 10 Years
Min: 11.52  Med: 15.50 Max: 18.41
Current: 11.53
11.52
18.41
ROC (Joel Greenblatt) (%) 44.37
WAT's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.41 vs. WAT: 44.37 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WAT' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 72.34  Med: 86.76 Max: 99.06
Current: 44.37
72.34
99.06
Revenue Growth (3Y)(%) 5.90
WAT's Revenue Growth (3Y)(%) is ranked higher than
56% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. WAT: 5.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WAT' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.2  Med: 8.90 Max: 17.8
Current: 5.9
5.2
17.8
EBITDA Growth (3Y)(%) 7.00
WAT's EBITDA Growth (3Y)(%) is ranked lower than
51% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.30 vs. WAT: 7.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WAT' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.4  Med: 11.00 Max: 69.2
Current: 7
2.4
69.2
EPS Growth (3Y)(%) 2.90
WAT's EPS Growth (3Y)(%) is ranked lower than
57% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.60 vs. WAT: 2.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WAT' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.6  Med: 14.60 Max: 79.9
Current: 2.9
2.6
79.9
» WAT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

WAT Guru Trades in Q2 2015

Ray Dalio 3,665 sh (New)
Paul Tudor Jones 5,788 sh (New)
Joel Greenblatt 89,108 sh (+91.84%)
Ruane Cunniff 2,050,465 sh (+0.06%)
Chuck Royce 15,450 sh (unchged)
Pioneer Investments Sold Out
Jeremy Grantham 128,515 sh (-6.48%)
John Hussman 20,000 sh (-25.93%)
PRIMECAP Management 711,722 sh (-26.90%)
Jim Simons 114,685 sh (-72.37%)
» More
Q3 2015

WAT Guru Trades in Q3 2015

Jim Simons 294,800 sh (+157.05%)
Ray Dalio 8,904 sh (+142.95%)
John Hussman 20,000 sh (unchged)
Ruane Cunniff 2,038,353 sh (-0.59%)
Chuck Royce 14,437 sh (-6.56%)
PRIMECAP Management 657,721 sh (-7.59%)
Paul Tudor Jones 5,300 sh (-8.43%)
Jeremy Grantham 54,090 sh (-57.91%)
Joel Greenblatt 25,527 sh (-71.35%)
» More
Q4 2015

WAT Guru Trades in Q4 2015

Jim Simons 296,696 sh (+0.64%)
Chuck Royce 14,437 sh (unchged)
Joel Greenblatt Sold Out
Ray Dalio Sold Out
PRIMECAP Management 651,117 sh (-1.00%)
Ruane Cunniff 1,995,247 sh (-2.11%)
John Hussman 15,000 sh (-25.00%)
Jeremy Grantham 36,790 sh (-31.98%)
Paul Tudor Jones 3,200 sh (-39.62%)
» More
Q1 2016

WAT Guru Trades in Q1 2016

Joel Greenblatt 24,086 sh (New)
Paul Tudor Jones Sold Out
John Hussman Sold Out
PRIMECAP Management 650,867 sh (-0.04%)
Ruane Cunniff 1,920,738 sh (-3.73%)
Chuck Royce 11,387 sh (-21.13%)
Jim Simons 169,200 sh (-42.97%)
Jeremy Grantham 2,109 sh (-94.27%)
» More
» Details

Insider Trades

Latest Guru Trades with WAT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:OTCPK:OCPNY, NYSE:MTD, NAS:HOLX, NAS:XRAY, NYSE:RMD, NYSE:COO, OTCPK:CLPBY, OTCPK:TRUMY, NYSE:BCR, NAS:SIRO, OTCPK:SAUHY, NYSE:STE, NYSE:WST, OTCPK:GNGBY, NYSE:HRC, NYSE:CMN, OTCPK:ANSLF, OTCPK:AMFPF, NAS:ILMN, NAS:PODD » details
Traded in other countries:WAZ.Germany,
Waters Corp is an analytical instrument manufacturer, that designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography & mass spectrometry instrument systems & support products.

Waters Corp was incorporated in Delaware in 1991. It is an analytical instrument manufacturer, mainly designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography, ultra performance liquid chromatography and mass spectrometry instrument systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Waters became a publicly-traded company with its initial public offering ("IPO") in November 1995. The Company's two operating segments, Waters Division and TA Division, have similar economic characteristics; product processes; products and services; types and classes of customers; methods of distribution and regulatory environments. The Waters Division's products and services consist of high performance liquid chromatography ("HPLC"), ultra performance liquid chromatography ("UPLC" and together with HPLC, referred to as "LC"), mass spectrometry ("MS") and chemistry consumable products and related services. TA products and services consist of thermal analysis, rheometry and calorimetry instrument systems and service sales. The Company's products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic and governmental customers. These customers use the Company's products to detect, identify, monitor and measure the chemical, physical and biological composition of materials and to predict the suitability of fine chemicals, pharmaceuticals, water, polymers and viscous liquids in various industrial, consumer goods and healthcare products. The Company's competitors include: Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Danaher Corporation and Thermo Fisher Scientific Inc. In the markets served by the TA Division, the Company's principal competitors include: PerkinElmer, Inc., Mettler-Toledo International Inc., NETZSCH-Geraetebau GmbH, Thermo Fisher Scientific Inc., Malvern Instruments Ltd., Anton-Paar and General Electric Company.

Top Ranked Articles about Waters Corp

Weekly Insider Sells Highlights: Walgreens Boots Alliance, Waters, Fitbit, Extra Space Storage A look at some of the companies with the most significant insider sells during the past week
According to GuruFocus Insider Data, the largest insider sells during the past week were: Walgreens Boots Alliance Inc. (NASDAQ:WBA), Waters Corp. (NYSE:WAT), Fitbit Inc. (NYSE:FIT), and Extra Space Storage Inc. (NYSE:EXR). Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 26.42
WAT's P/E(ttm) is ranked higher than
57% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.89 vs. WAT: 26.42 )
Ranked among companies with meaningful P/E(ttm) only.
WAT' s P/E(ttm) Range Over the Past 10 Years
Min: 9.64  Med: 20.91 Max: 32.25
Current: 26.42
9.64
32.25
Forward P/E 24.69
WAT's Forward P/E is ranked lower than
56% of the 41 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.32 vs. WAT: 24.69 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 26.42
WAT's PE(NRI) is ranked higher than
57% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.89 vs. WAT: 26.42 )
Ranked among companies with meaningful PE(NRI) only.
WAT' s PE(NRI) Range Over the Past 10 Years
Min: 9.64  Med: 20.91 Max: 32.25
Current: 26.42
9.64
32.25
Price/Owner Earnings (ttm) 29.66
WAT's Price/Owner Earnings (ttm) is ranked higher than
53% of the 76 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.98 vs. WAT: 29.66 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
WAT' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 10.12  Med: 21.79 Max: 34.46
Current: 29.66
10.12
34.46
P/B 5.95
WAT's P/B is ranked lower than
77% of the 207 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. WAT: 5.95 )
Ranked among companies with meaningful P/B only.
WAT' s P/B Range Over the Past 10 Years
Min: 4.38  Med: 6.36 Max: 19.91
Current: 5.95
4.38
19.91
P/S 6.32
WAT's P/S is ranked lower than
75% of the 212 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. WAT: 6.32 )
Ranked among companies with meaningful P/S only.
WAT' s P/S Range Over the Past 10 Years
Min: 2.06  Med: 4.42 Max: 6.34
Current: 6.32
2.06
6.34
PFCF 28.30
WAT's PFCF is ranked lower than
54% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.29 vs. WAT: 28.30 )
Ranked among companies with meaningful PFCF only.
WAT' s PFCF Range Over the Past 10 Years
Min: 9.71  Med: 21.21 Max: 30.1
Current: 28.3
9.71
30.1
POCF 22.99
WAT's POCF is ranked lower than
68% of the 103 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.88 vs. WAT: 22.99 )
Ranked among companies with meaningful POCF only.
WAT' s POCF Range Over the Past 10 Years
Min: 7.86  Med: 17.26 Max: 24.72
Current: 22.99
7.86
24.72
EV-to-EBIT 20.83
WAT's EV-to-EBIT is ranked higher than
56% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.84 vs. WAT: 20.83 )
Ranked among companies with meaningful EV-to-EBIT only.
WAT' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.1  Med: 16.20 Max: 23.6
Current: 20.83
8.1
23.6
EV-to-EBITDA 17.96
WAT's EV-to-EBITDA is ranked higher than
51% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.39 vs. WAT: 17.96 )
Ranked among companies with meaningful EV-to-EBITDA only.
WAT' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7  Med: 14.10 Max: 20.6
Current: 17.96
7
20.6
PEG 4.04
WAT's PEG is ranked lower than
64% of the 61 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. WAT: 4.04 )
Ranked among companies with meaningful PEG only.
WAT' s PEG Range Over the Past 10 Years
Min: 0.58  Med: 1.59 Max: 4.47
Current: 4.04
0.58
4.47
Shiller P/E 35.10
WAT's Shiller P/E is ranked higher than
62% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.46 vs. WAT: 35.10 )
Ranked among companies with meaningful Shiller P/E only.
WAT' s Shiller P/E Range Over the Past 10 Years
Min: 16.73  Med: 29.91 Max: 52.03
Current: 35.1
16.73
52.03
Current Ratio 6.32
WAT's Current Ratio is ranked higher than
87% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.51 vs. WAT: 6.32 )
Ranked among companies with meaningful Current Ratio only.
WAT' s Current Ratio Range Over the Past 10 Years
Min: 1.19  Med: 1.88 Max: 6.32
Current: 6.32
1.19
6.32
Quick Ratio 5.77
WAT's Quick Ratio is ranked higher than
91% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. WAT: 5.77 )
Ranked among companies with meaningful Quick Ratio only.
WAT' s Quick Ratio Range Over the Past 10 Years
Min: 0.74  Med: 1.52 Max: 5.77
Current: 5.77
0.74
5.77
Days Inventory 117.27
WAT's Days Inventory is ranked higher than
58% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.38 vs. WAT: 117.27 )
Ranked among companies with meaningful Days Inventory only.
WAT' s Days Inventory Range Over the Past 10 Years
Min: 96.3  Med: 107.44 Max: 110.42
Current: 117.27
96.3
110.42
Days Sales Outstanding 77.55
WAT's Days Sales Outstanding is ranked lower than
72% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.94 vs. WAT: 77.55 )
Ranked among companies with meaningful Days Sales Outstanding only.
WAT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.61  Med: 79.15 Max: 83.7
Current: 77.55
67.61
83.7
Days Payable 30.88
WAT's Days Payable is ranked lower than
77% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.12 vs. WAT: 30.88 )
Ranked among companies with meaningful Days Payable only.
WAT' s Days Payable Range Over the Past 10 Years
Min: 26.08  Med: 29.67 Max: 35.98
Current: 30.88
26.08
35.98

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 12.38
WAT's Price/Net Current Asset Value is ranked lower than
64% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.62 vs. WAT: 12.38 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
WAT' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 9.08  Med: 17.57 Max: 310.33
Current: 12.38
9.08
310.33
Price/Tangible Book 8.10
WAT's Price/Tangible Book is ranked lower than
76% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.52 vs. WAT: 8.10 )
Ranked among companies with meaningful Price/Tangible Book only.
WAT' s Price/Tangible Book Range Over the Past 10 Years
Min: 6.37  Med: 12.23 Max: 1545.29
Current: 8.1
6.37
1545.29
Price/Projected FCF 2.08
WAT's Price/Projected FCF is ranked lower than
51% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.91 vs. WAT: 2.08 )
Ranked among companies with meaningful Price/Projected FCF only.
WAT' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.87  Med: 1.64 Max: 11.02
Current: 2.08
0.87
11.02
Price/DCF (Earnings Based) 1.54
WAT's Price/DCF (Earnings Based) is ranked higher than
67% of the 18 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.91 vs. WAT: 1.54 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.43
WAT's Price/Median PS Value is ranked lower than
65% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. WAT: 1.43 )
Ranked among companies with meaningful Price/Median PS Value only.
WAT' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.24  Med: 0.98 Max: 3.54
Current: 1.43
0.24
3.54
Price/Peter Lynch Fair Value 4.46
WAT's Price/Peter Lynch Fair Value is ranked lower than
71% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. WAT: 4.46 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
WAT' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.65  Med: 1.59 Max: 5.81
Current: 4.46
0.65
5.81
Price/Graham Number 3.08
WAT's Price/Graham Number is ranked lower than
61% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. WAT: 3.08 )
Ranked among companies with meaningful Price/Graham Number only.
WAT' s Price/Graham Number Range Over the Past 10 Years
Min: 2.34  Med: 3.42 Max: 49.57
Current: 3.08
2.34
49.57
Earnings Yield (Greenblatt) (%) 4.82
WAT's Earnings Yield (Greenblatt) (%) is ranked higher than
77% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.33 vs. WAT: 4.82 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WAT' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.2  Med: 6.20 Max: 12.4
Current: 4.82
4.2
12.4
Forward Rate of Return (Yacktman) (%) 9.19
WAT's Forward Rate of Return (Yacktman) (%) is ranked higher than
55% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.73 vs. WAT: 9.19 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
WAT' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.2  Med: 15.90 Max: 26.3
Current: 9.19
9.2
26.3

More Statistics

Revenue (TTM) (Mil) $2,099
EPS (TTM) $ 5.95
Beta0.74
Short Percentage of Float4.80%
52-Week Range $112.00 - 159.46
Shares Outstanding (Mil)80.94

Analyst Estimate


Warning: Invalid argument supplied for foreach() in /home/gurufocu/public_html/modules/stock/estimate.php on line 163
Dec16 Dec17 Dec18
Revenue (Mil $) 2,148 2,263 2,419
EPS ($) 6.36 6.95 7.68
EPS w/o NRI ($) 6.36 6.95 7.68
EPS Growth Rate
(3Y to 5Y Estimate)
7.34%
Dividends Per Share ($)
» More Articles for WAT

Headlines

Articles On GuruFocus.com
Companies Hit 52-Week Highs Jul 19 2016 
My Favorite Health Care Stocks Jul 12 2016 
5 Companies Hit Their 52-Week Highs May 31 2016 
Should You Wait to Bet on Agilent Technologies? Dec 20 2015 
Weekly Insider Sells Highlights: Walgreens Boots Alliance, Waters, Fitbit, Extra Space Storage Nov 24 2015 
Weekly Insider Sells Highlight: WAT, KO, GILD, AZO, MAS Dec 14 2014 
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY Dec 08 2014 
Our Investment Strategy and Portfolio Selection Nov 09 2014 
Guru-Held Stocks Trading At Historical Low P/B Oct 08 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 

More From Other Websites
Frontier Communications (FTR): Earnings Preview for Q2 Jul 28 2016
AMC Entertainment (AMC) Q2 Earnings: What to Expect? Jul 28 2016
Waters Corp. :WAT-US: Earnings Analysis: Q2, 2016 By the Numbers : July 27, 2016 Jul 27 2016
Edited Transcript of WAT earnings conference call or presentation 26-Jul-16 12:00pm GMT Jul 26 2016
Waters Corp. (WAT) Q2 Earnings Beat on Top Line Strength Jul 26 2016
Waters Corp Earnings Call scheduled for 8:00 am ET today Jul 26 2016
Waters Reports Second Quarter 2016 Financial Results Jul 26 2016
Waters Corp. (WAT) Q2 Earnings and Revenues Trump Estimates Jul 26 2016
Q2 2016 Waters Corp Earnings Release - Before Market Open Jul 26 2016
WATERS CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 26 2016
Waters beats Street 2Q forecasts Jul 26 2016
Waters beats Street 2Q forecasts Jul 26 2016
6:52 am Waters beats by $0.13, beats on revs Jul 26 2016
Waters Reports Second Quarter 2016 Financial Results Jul 26 2016
5 Growth Stocks to Buy as Markets Rally Over Last 4 Weeks Jul 25 2016
Why Waters (WAT) Might Surprise This Earnings Season Jul 25 2016
Waters Corp. (WAT) Q2 Preview: Will It Beat Earnings Again? Jul 22 2016
Research Reports on Facebook (FB), Tesla (TSLA) & Others Jul 21 2016
Companies Hit 52-Week Highs Jul 19 2016
ETF’s with exposure to Waters Corp. : July 19, 2016 Jul 19 2016
VICAM, a Waters Business, Receives 2016 North American Food Safety Diagnostics Market Leadership... Jul 14 2016
VICAM, a Waters Business, Receives 2016 North American Food Safety Diagnostics Market Leadership... Jul 14 2016
Waters Corporation Q2 2016 Financial Results Webcast Invitation Jul 06 2016
Waters Corporation Q2 2016 Financial Results Webcast Invitation Jul 06 2016
ETF’s with exposure to Waters Corp. : June 30, 2016 Jun 30 2016
Waters Corp. :WAT-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 Jun 28 2016
MultiModal Molecular Imaging Institute at Maastricht University Joins Waters Centers of Innovation... Jun 22 2016
Waters Collaborates with Singapore’s Bioprocessing Technology Institute to Develop New Strategies... Jun 21 2016
Waters Collaborates with Singapore’s Bioprocessing Technology Institute to Develop New Strategies... Jun 21 2016
Waters Announces New Reference Library for Metabolite Profiling by Ion Mobility Separations Jun 06 2016
Waters New Symphony Data Pipeline Software for Personalized Data Processing Jun 02 2016
Waters Corporation Presentation at the Goldman Sachs 37th Annual Global Healthcare Conference to Be... Jun 01 2016
Waters Corporation Presentation at the UBS Global Healthcare Conference to Be Webcast Live May 16 2016
Waters Introduces Xevo TQ-XS, the Most Sensitive Benchtop Mass Spectrometer Available May 16 2016
Waters tops Street 1Q forecasts Apr 26 2016
Waters Reports First Quarter 2016 Financial Results Apr 26 2016
Waters Corporation Q1 2016 Financial Results Webcast Invitation Apr 05 2016
Waters and BioCity Debut New Open Access Analytical Laboratory in the BioHub at Alderley Park, UK Feb 11 2016
Waters Introduces CORTECS C8 and Phenyl 1.6 and 2.7 Micron Columns Feb 01 2016
Waters beats Street 4Q forecasts Jan 26 2016
Waters Corporation Expands Executive Team Jan 25 2016
Waters Named 2015 "Company of the Year" by Instrument Business Outlook Jan 22 2016
Waters Corporation Presentation at The 34th Annual J.P. Morgan Healthcare Conference to Be Webcast... Jan 06 2016
Waters and BioCity to Establish an Open Access Analytical Laboratory in the BioHub at Alderley Park,... Jan 06 2016
Waters Corporation Q4 2015 Financial Results Webcast Invitation Jan 05 2016
Waters ACQUITY UPLC I-Class/Xevo TQ-S micro System available as a U.S. FDA Class I, CE-Marked... Jan 05 2016
Waters tops Street 3Q forecasts Oct 27 2015
Waters tops Street 2Q forecasts Jul 28 2015
Stocks end mostly higher as company earnings reports pour in Apr 28 2015
Waters tops Street 1Q forecasts Apr 28 2015
Waters beats Street 4Q forecasts Jan 26 2015
Waters tops Street 4Q forecasts Jan 26 2015
Waters Corp. tops Street 3rd-quarter forecasts Oct 21 2014
Nestle takes step towards customisable vitamins Jun 23 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)